clonazepam has been researched along with stilbenes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lerner, PP; Lerner, V; Miodownik, C | 1 |
| Arbabi, E; Atyabi, F; Dinarvand, R; Hassanzadeh, P | 1 |
1 review(s) available for clonazepam and stilbenes
| Article | Year |
|---|---|
Tardive dyskinesia (syndrome): Current concept and modern approaches to its management.
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; alpha-Tocopherol; Amantadine; Anticonvulsants; Antioxidants; Antipsychotic Agents; Clonazepam; Dopamine Agents; Drugs, Chinese Herbal; Fatty Acids, Omega-3; Ginkgo biloba; Humans; Isoleucine; Isoxazoles; Leucine; Levetiracetam; Melatonin; Movement Disorders; Nootropic Agents; Piracetam; Plant Extracts; Propranolol; Pyridoxine; Resveratrol; Stilbenes; Tetrabenazine; Valine; Vitamins; Zonisamide | 2015 |
1 other study(ies) available for clonazepam and stilbenes
| Article | Year |
|---|---|
The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders.
Topics: Amitriptyline; Animals; Antioxidants; Brain; Camphanes; Cannabinoids; Clonazepam; Dose-Response Relationship, Drug; Endocannabinoids; Male; Nerve Growth Factor; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Resveratrol; Signal Transduction; Stilbenes | 2016 |